Skip to main content
. 2018 Apr 26;9:279. doi: 10.3389/fneur.2018.00279

Table 1.

Overview of the demographic and clinical characteristics of the impulse control disorder (ICD)+ and ICD− groups (mean ± SD).

Measure PD ICD+ PD ICD− Group difference
# subjects 21 30
Age (years) 60 ± 5 62 ± 8 t(49) = −3.92, p = 0.69
Gender 7 F/14 M 11 F/19 M χ2(1) = 0.06, p = 0.80
Handedness 3 L/18 R 4 L/26 R χ2(1) = 0.01, p = 0.92
Age of PD onset (years)a 55.9 ± 6.2 58.1 ± 8.4 t(47) = −0.99, p = 0.32
Disease duration (months)a 57.3 ± 30.7 44.2 ± 37.7 t(47) = 1.31, p = 0.19
LED (mg) 561 ± 322 486 ± 332 t(49) = 0.80, p = 0.42
UPDRS motor 25.95 ± 9.92 25.33 ± 9.49 t(49) = 0.22, p = 0.82
BIS total score 61.90 ± 15.16 54.10 ± 8.85 t(49) = 2.32, p = 0.025
 Attentional impulsiveness 16.33 ± 5.25 14.00 ± 3.47 t(49) = 1.91, p = 0.062
 Motor impulsiveness 21.90 ± 4.93 19.10 ± 2.99 t(49) = 2.53, p = 0.015
 Non-planning impulsiveness 23.67 ± 6.39 21.00 ± 4.55 t(49) = 1.74, p = 0.088
MoCA 27.95 ± 1.59 27.33 ± 1.54 t(49) = 1.39, p = 0.17
NART-R (FSIQ score) 112.49 ± 7.58 112.25 ± 5.56 t(49) = 0.13, p = 0.89

aData from two patients in the ICD− group were missing.

PD, Parkinson’s disease; BIS, Barratt Impulsiveness Scale; MoCA, Montreal Cognitive Assessment; NART-R, National Adult Reading Test-Revised; FSIQ, Full Scale IQ; LED, Levodopa Equivalent Dose; UPDRS, Unified Parkinson’s Disease Rating Scale.